Christopher J Mortko

Summary

Affiliation: Merck Research Laboratories
Country: USA

Publications

  1. ncbi Risk assessment and physicochemical characterization of a metastable dihydrate API phase for intravenous formulation development
    Christopher J Mortko
    Basic Pharmaceutical Sciences, Merck and Co, Inc, 126 E Lincoln Avenue, Rahway, New Jersey 07065, USA
    J Pharm Sci 99:4973-81. 2010
  2. ncbi Rapid conversion of API hydrates to anhydrous forms in aqueous media
    Rositza I Petrova
    Merck and Co, Inc, RY818 B112, P O Box 2000, Rahway, New Jersey 07065, USA
    J Pharm Sci 98:4111-8. 2009

Detail Information

Publications2

  1. ncbi Risk assessment and physicochemical characterization of a metastable dihydrate API phase for intravenous formulation development
    Christopher J Mortko
    Basic Pharmaceutical Sciences, Merck and Co, Inc, 126 E Lincoln Avenue, Rahway, New Jersey 07065, USA
    J Pharm Sci 99:4973-81. 2010
    ....
  2. ncbi Rapid conversion of API hydrates to anhydrous forms in aqueous media
    Rositza I Petrova
    Merck and Co, Inc, RY818 B112, P O Box 2000, Rahway, New Jersey 07065, USA
    J Pharm Sci 98:4111-8. 2009
    ..The rate of conversion in a dry state was found to depend on the relative humidity (RH) and was highest at the two RH extremes examined, 5% and 97.5% RH...